Mergers & Acquisitions

  • April 27, 2026

    Altria, Juul Can Appeal Class Cert. Decision In Antitrust Suit

    The Ninth Circuit on Monday granted Altria and Juul's request to appeal a ruling certifying several classes of e-cigarette buyers in an antitrust case alleging the companies schemed to have Altria exit the e-cigarette market.

  • April 27, 2026

    United CEO Touts Merger Benefits Despite American Rebuff

    United Airlines' chief executive pressed the merits of a mega airline merger Monday, while also confirming recent reports that he had approached American Airlines about exploring a potential combination, and that American shut the door on any such talks.

  • April 27, 2026

    China Blocks Meta's Planned $2B Manus AI Acquisition

    China's top economic planning body on Monday ordered the cancellation of Meta Platforms Inc.'s planned acquisition of Chinese artificial intelligence company Manus.

  • April 27, 2026

    Tech Brokerage Real To Acquire Re/Max In $880M Deal

    Miami-based, technology-focused firm Real Brokerage said Monday that it will acquire Re/Max Holdings in a deal valuing the franchisor at $880 million, with advice from Willkie Farr & Gallagher LLP, Gowling WLG LLP and Morrison Foerster LLP.

  • April 27, 2026

    How A Rush To Trial Paid Off With A Rare FCPA Acquittal

    A defense strategy to fast-track the trial in a yearslong criminal foreign bribery case against a Mexican businessman in Texas appeared to backfire when he was convicted and sent to prison last year, but the gamble ultimately paid off when a judge permanently tossed the case earlier this month.

  • April 27, 2026

    Trump SPAC, Ex-CEO Clash Over $2M In Fees

    A Delaware Chancery Court hearing Monday laid bare a procedural fight over whether a Trump-linked SPAC must immediately pay disputed legal fees to its former CEO or can withhold them while seeking review of a magistrate's ruling.

  • April 27, 2026

    IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

    IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.

  • April 27, 2026

    AGs Say Live Nation Fix Can't Wait On DOJ Deal Approval

    Live Nation Entertainment Inc. sparred with state attorneys general expected to seek a forced Ticketmaster sale after winning a New York federal jury antitrust verdict, with the company seeking to delay the breakup fight until after the judge reviews a separate U.S. Department of Justice settlement, and the enforcers preferring parallel proceedings.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week tackled a fresh mix of deal litigation, procedural disputes and fiduciary duty claims, with several rulings and filings underscoring the court's continued focus on contractual precision, forum enforcement and the limits of stockholder challenges.

  • April 27, 2026

    V&E Expands Corporate Practice With 4 WilmerHale Attys

    Vinson & Elkins LLP announced Monday that it has bolstered its corporate practice with four former WilmerHale attorneys who advise companies and private equity clients in a wide range of corporate and securities matters.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

    Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.

  • April 27, 2026

    FTC Wants More Info On IonQ's $1.8B Chipmaker Deal

    The Federal Trade Commission has requested additional information about quantum computing company IonQ's planned $1.8 billion purchase of semiconductor maker SkyWater Technology, extending a waiting period that prevents the transaction from closing.

  • April 27, 2026

    Shell To Acquire Canada's ARC Resources For $13.6B

    Oil giant Shell PLC said Monday that it has agreed to buy Canadian energy company ARC Resources Ltd. for $13.6 billion in a cash and stock deal to boost and diversify its energy output.

  • April 27, 2026

    Justices Turn Away Lebanese Bank Terrorism Suit

    The U.S. Supreme Court declined Monday to review the Second Circuit's finding that a Lebanese bank is subject to the personal jurisdiction of New York courts on claims over alleged assistance to Hezbollah by a bank it acquired, a case the Lebanese bank had argued raises due process questions.

  • April 27, 2026

    Kirkland Helps Apollo Buy Forvia's Interiors Biz For €1.8B

    U.S. private equity shop Apollo said Monday that it will buy the vehicle interiors business from French automotive supplier Forvia SE in a €1.82 billion ($2.1 billion) carveout deal.

  • April 24, 2026

    Alaska Airlines Escapes Suit Over Hawaiian Merger, For Now

    A Hawaiian federal judge on Friday dismissed a private antitrust lawsuit that challenged Alaska Airlines' 2024 acquisition of Hawaiian Airlines, rejecting the passengers' asserted geographic markets and their contention that the merger would lead to anticompetitive effects in the markets.

  • April 24, 2026

    GPGI Faces Suit Over Nevada Reincorporation

    A GPGI Inc. investor has filed suit in Delaware seeking to challenge the company's planned move to Nevada, saying the reincorporation — part of a wider trend of companies weighing exits from Delaware — would benefit insiders while limiting stockholders' ability to pursue claims tied to earlier transactions.

  • April 24, 2026

    Merck's $6.7B Terns Deal Clears Regulatory Hurdle

    Merck has cleared a key regulatory hurdle in its plan to acquire clinical stage oncology company Terns Pharmaceuticals Inc. for $6.7 billion, the pharmaceutical giant said Friday. 

  • April 24, 2026

    Don't Miss It: Ropes, Simpson Thacher Steer Week's Hot Deals

    A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple of weeks, and it's difficult to keep up with all the deals.

  • April 24, 2026

    Porsche Selling Bugatti Rimac Stakes To PE-Led Consortium

    German automobile manufacturer Porsche announced Friday that it is selling its equity stakes in Bugatti Rimac and Rimac Group to a consortium led by New York-based investment firm HOF Capital.

  • April 24, 2026

    Taxation With Representation: Gibson Dunn, Paul Weiss

    In this week's Taxation With Representation, Elon Musk's SpaceX strikes a deal with Cursor that could lead to an acquisition of the artificial intelligence startup, building products distributor QXO Inc. buys TopBuild Corp., and Eli Lilly & Co. acquires clinical-stage biotechnology company Kelonia Therapeutics.

  • April 24, 2026

    Canada's Cohere To Merge With German AI Rival Aleph Alpha

    Cohere, a Canadian developer of large language models, said Friday that it plans to combine with German rival Aleph Alpha in order to create a transatlantic artificial intelligence powerhouse.

  • April 23, 2026

    Car Parts Co.'s Acquisition Integration Failed, Investors Say

    Auto parts distributor LKQ Corp. has been hit with a proposed class action in Tennessee federal court accusing it of concealing that a 2023 acquisition harmed LKQ's ability to meet its financial growth goals.

Expert Analysis

  • Anticipating FTC's Shift On Unfair Competition Enforcement

    Author Photo

    As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.

  • Del. Dispatch: Chancery Expands On Caremark Red Flags

    Author Photo

    The Delaware Court of Chancery’s recent Brewer v. Turner decision, allowing a shareholder derivative suit against the board of Regions Bank to proceed, takes a more expansive view as to what constitutes red flags, bad faith and corporate trauma in Caremark claims, say attorneys at Fried Frank.

  • Opinion

    It's Time For The Judiciary To Fix Its Cybersecurity Problem

    Author Photo

    After recent reports that hackers have once again infiltrated federal courts’ electronic case management systems, the judiciary should strengthen its cybersecurity practices in line with executive branch standards, outlining clear roles and responsibilities for execution, says Ilona Cohen at HackerOne.

  • Considering Judicial Treatment Of The 2023 Merger Guidelines

    Author Photo

    Courts have so far primarily cited the 2023 merger guidelines for propositions that do not differ significantly from prior versions of the guidelines, leaving it unclear whether the antitrust agencies will test the guidelines’ more aggressive theories, and how those theories will be treated by federal judges, say attorneys at Covington.

  • Federal Debanking Scrutiny Prompts Compliance Questions

    Author Photo

    Recent U.S. Small Business Administration guidance sets forth requirements for preventing so-called politicized debanking and specific additional instructions for small lenders, but falls short on clarity for larger institutions, leaving lenders of all sizes with questions as they navigate this unique compliance challenge, say attorneys at Cooley.

  • Series

    Writing Novels Makes Me A Better Lawyer

    Author Photo

    Writing my debut novel taught me to appreciate the value of critique and to never give up, no matter how long or tedious the journey, providing me with valuable skills that I now emphasize in my practice, says Daniel Buzzetta at BakerHostetler.

  • SEC's No-Action Relief Could Dramatically Alter Retail Voting

    Author Photo

    The U.S. Securities and Exchange Commission recently cleared the way for ExxonMobil to institute a novel change in retail shareholder voting that could greatly increase voter turnout, granting no-action relief that represents an effective and meaningful step toward modernizing the shareholder voting process and the much-needed democratization of retail investors, say attorneys at Cozen.

  • SDNY OpenAI Order Clarifies Preservation Standards For AI

    Author Photo

    The Southern District of New York’s recent order in the OpenAI copyright infringement litigation, denying discovery of The New York Times' artificial intelligence technology use, clarifies that traditional preservation benchmarks apply to AI content, relieving organizations from using a “keep everything” approach, says Philip Favro at Favro Law.

  • What's At Stake In Justices' Merits Hearing Of FTC Firing

    Author Photo

    In December, the U.S. Supreme Court will review President Donald Trump's firing of Democratic Federal Trade Commissioner Rebecca Slaughter, a decision that will implicate a 90-year-old precedent and, depending on its breadth, could have profound implications for presidential authority over independent agencies, say attorneys at Holland & Knight.

  • 6 Shifts In Trump Tax Law May Lend A Hand To M&A Strategy

    Author Photo

    Changes in the Trump administration's recent One Big Beautiful Bill Act stand to create a more favorable environment for mergers and acquisitions, including full bonus depreciation and an expanded code section, say attorneys at K&L Gates.

  • Hermes Bags Antitrust Win That Clarifies Luxury Tying Claims

    Author Photo

    A California federal court recently found that absent actual harm to competition in the market for ancillary products, Hermes may make access to the Birkin bag contingent on other purchases, establishing that selective sales tactics and scarcity do not automatically violate U.S. antitrust law, say attorneys at Holland & Knight.

  • Opinion

    High Court, Not A Single Justice, Should Decide On Recusal

    Author Photo

    As public trust in the U.S. Supreme Court continues to decline, the court should adopt a collegial framework in which all justices decide questions of recusal together — a reform that respects both judicial independence and due process for litigants, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Series

    Traveling Solo Makes Me A Better Lawyer

    Author Photo

    Traveling by myself has taught me to assess risk, understand tone and stay calm in high-pressure situations, which are not only useful life skills, but the foundation of how I support my clients, says Lacey Gutierrez at Group Five Legal.

  • Series

    Law School's Missed Lessons: Client Service

    Author Photo

    Law school teaches you how to interpret the law, but it doesn't teach you some of the key ways to keeping clients satisfied, lessons that I've learned in the most unexpected of places: a book on how to be a butler, says Gregory Ramos at Armstrong Teasdale.

  • US-German M&A Hits Its Stride Despite Economic Headwinds

    Author Photo

    Against expectations, dealmakers in both the U.S. and Germany are actively seeking investment opportunities in each other's markets, with 2025 shaping up to be the strongest year in recent memory, say attorneys at White & Case.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.